FDA Grants Emergency Use Authorization for Lotilaner
The FDA has issued an emergency use authorization for lotilaner (Credelio; Elanco Animal Health Incorporated) to treat New World screwworm (NWS) infestations in dogs.
This authorization is the first of its kind for dogs, as health officials track NWS cases near the US–Mexico border, with confirmed cases less than 70 miles south of the border.
"This first-ever Emergency Use Authorization for NWS in dogs gives veterinarians and pet owners peace of mind, knowing there's an authorized treatment option available as soon as they may need it,"
said Ellen de Brabander, PhD, executive vice president of innovation and regulatory affairs at Elanco.
This announcement marks a significant development in the treatment of NWS in dogs.
Author summary: FDA authorizes lotilaner for NWS treatment in dogs.
More News
- Sault's new website is missing parts
- How do you solve a problem like Giannis?
- Bloodanooga returns to UTC as Blood Assurance is facing a critical platelet shortage - WDEF
- The European Bank considers supporting and financing the national carrier
- Trump Stops Biden’s Euro-Style Solution to Flight Delays and Paves Way To Lower Fares
- Police engage Sampa schools to assure peace, counter fear of teacher transfers - MyJoyOnline